Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Luminate vs Avastin in DME
NCT02348918Phase 2Completed
- Sponsor
- Allegro Ophthalmics, LLC
- Start
- Oct 2014
- Primary completion
- May 2017
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of risuteganib in diabetic macular edema (DME), sponsored by Allegro Ophthalmics, LLC. Started Oct 2014; status: completed.
02
Drugs
risuteganib
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT02348918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02348918.